Spanish Pharmaceuticals & Biotech Price disconnect

Grifols

Market Cap: €6.1b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

Almirall

Market Cap: €2.4b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

Labiana Health

Market Cap: €54.4m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.